Oragenics Inc (AMEX: OGEN) started the day on Thursday, with a price increase of 11.74% at $1.08, before settling in for the price of $0.97 at the close. Taking a more long-term approach, OGEN posted a 52-week range of $0.86-$7.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been -20.00% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 29.34%. This publicly-traded company’s shares outstanding now amounts to $5.58 million, simultaneously with a float of $5.05 million. The organization now has a market capitalization sitting at $6.03 million. At the time of writing, stock’s 50-day Moving Average stood at $1.2928, while the 200-day Moving Average is $2.6142.
Oragenics Inc (OGEN) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Oragenics Inc’s current insider ownership accounts for 9.50%, in contrast to 3.53% institutional ownership. According to the most recent insider trade that took place on Nov 30 ’23, this organization’s Director sold 3,500 shares at the rate of 3.57, making the entire transaction reach 12,488 in total value, affecting insider ownership by 38,345.
Oragenics Inc (OGEN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
Oragenics Inc (AMEX: OGEN) Trading Performance Indicators
Let’s observe the current performance indicators for Oragenics Inc (OGEN). It’s Quick Ratio in the last reported quarter now stands at 2.69. The Stock has managed to achieve an average true range (ATR) of 0.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 301.32.
In the same vein, OGEN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -7.20.
Technical Analysis of Oragenics Inc (OGEN)
If we take a close look at the recent performances of Oragenics Inc (AMEX: OGEN), its last 5-days Average volume was 2.25 million that shows progress from its year to date volume of 0.18 million. During the previous 9 days, stock’s Stochastic %D was recorded 39.39% While, its Average True Range was 0.1298.
Raw Stochastic average of Oragenics Inc (OGEN) in the period of the previous 100 days is set at 8.52%, which indicates a major fall in contrast to 41.39% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 70.98% that was lower than 135.23% volatility it exhibited in the past 100-days period.
